Journal «Angiology and Vascular Surgery» • 

2005 • VOLUME 11 • №1

ALPROSTAN FOR MANAGEMENT OF CRITICAL LOWER LIMB ISCHEMIA

A.V. Pokrovsky, V.N. Dan, A.V. Chupin, A.A. Kalinin
Department of Vascular Surgery, A.V. Vishnevsky Institute of Surgery,
Moscow, Russia

A clinical trial on Alprostan (prostaglandin E1) use for management of critical lower limb ischemia (Fontaine-Pokrovsky stages III and IV of chronic limb ischemia) was carried out in A.V. Vishnevsky Institute of Surgery from March, 2003 till April, 2004. The study aimed at appraisal of Alprostan effectiveness (administered alone or combined with reconstructive interventions) in coping with critical ischemia in patients with lower limb arterial occlusive lesions.

KEY WORDS: critical lower limb ischemia, prostaglandin E1.

P. 10

« Back

Angiologia.ru - portal for professionals
VLAANT
Lancet
HI-TECHNOLOGY MEDICINE